Patients’ attitudes towards deprescribing disease modifying anti-rheumatic drugs in rheumatoid arthritis
Clinicians should be encouraged to initiate deprescribing discussions, especially in stable rheumatoid arthritis, however, shared decision-making should involve identifying and addressing concerns patients have about deprescribing their DMARDs.
Authors
- Emily Reeve (ORCID: https://orcid.org/0000-0002-1405-999X)
- Caroline Sirois (ORCID: https://orcid.org/0000-0003-3294-7883)
- Susanna Proudman (ORCID: https://orcid.org/0000-0002-3046-9884)
- Lisa M. Kalisch Ellett (ORCID: https://orcid.org/0000-0001-5063-6128)
- Leah McWilliams
- William Berthelot (ORCID: https://orcid.org/0009-0001-7304-670X)
- Michael D. Wiese (ORCID: https://orcid.org/0000-0002-3255-9242)
- Nagham Ailabouni (ORCID: https://orcid.org/0000-0002-6732-745X)
- Lauren Fraser (ORCID: https://orcid.org/0000-0002-4527-9872)
Institutions
- Royal Adelaide Hospital (AU)
- The University of Queensland (AU)
- University of South Australia (AU)
- Monash Medical Centre (AU)
- Université Laval (CA)
- Monash University (AU)
- The University of Adelaide (AU)
Publication Details
- Journal
- Patient Education and Counseling
- Published
- 2025-11-22
- DOI
- https://doi.org/10.1016/j.pec.2025.109432
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00